Discuss your habits with your provider
The right approach depends on your practice size, specialty, PA volume, and budget
For most patients taking GLP-1 medications, maintaining a balanced diet, staying physically active, and ensuring adequate calcium and vitamin D intake will support bone health throughout treatment
Top line results showed the glucagon-like peptide-1 (GLP-1) receptor agonist slowed progression of kidney disease in people with type 2 diabetes and reduced both kidney outcomes and cardiovascular mortality
Concurrent Use with Other NNMT Inhibitors or Methylation Modulators Combining with supplements or drugs that also inhibit NNMT or alter methylation (e.g., SAMe , niacin , methylfolate , resveratrol ) could lead to: Excess NAD accumulation Methyl donor depletion Unpredictable metabolic effects Use caution and monitor methylation-related pathways if stacking 3